{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:25:59Z","timestamp":1760865959848},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T00:00:00Z","timestamp":1460073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/pr.2016.75","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T17:39:07Z","timestamp":1460137147000},"page":"252-257","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients"],"prefix":"10.1038","volume":"80","author":[{"given":"Akitaka","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Taga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"BFpr201675_CR1","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1182\/blood-2006-10-054528","volume":"109","author":"S Kishi","year":"2007","unstructured":"Kishi S, Cheng C, French D, et al. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood 2007;109:4151\u20137.","journal-title":"Blood"},{"key":"BFpr201675_CR2","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","volume":"269","author":"PJ Bosma","year":"1994","unstructured":"Bosma PJ, Seppen J, Goldhoorn B, et al. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 1994;269:17960\u20134.","journal-title":"J Biol Chem"},{"key":"BFpr201675_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/187569210791383901","volume":"8","author":"Y Maruo","year":"2010","unstructured":"Maruo Y, Takahashi H, Matsui K, Sato H, Takeuchi Y. Phase II drug metabolism and individualized drug therapy: a focus on functional genetic variation in UDP-glucuronosyltransferases. Curr Pharmacogenomics Person Med 2010; 8:146\u2013166.","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"BFpr201675_CR4","first-page":"241","volume":"21","author":"A Gilbert","year":"1901","unstructured":"Gilbert A, Lereboullet P. La chol\u00e9mie simple familiale. Semaine Med 1901;21:241\u20133.","journal-title":"Semaine Med"},{"key":"BFpr201675_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jmg.12.2.152","volume":"12","author":"D Owens","year":"1975","unstructured":"Owens D, Evans J. Population studies on Gilbert\u2019s syndrome. J Med Genet 1975;12:152\u20136.","journal-title":"J Med Genet"},{"key":"BFpr201675_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1055\/s-2008-1068222","volume":"112","author":"A Sieg","year":"1987","unstructured":"Sieg A, Arab L, Schlierf G, Stiehl A, Kommerell B. [Prevalence of Gilbert\u2019s syndrome in Germany]. Dtsch Med Wochenschr 1987;112:1206\u20138.","journal-title":"Dtsch Med Wochenschr"},{"key":"BFpr201675_CR7","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/S0021-9258(19)50724-4","volume":"267","author":"JK Ritter","year":"1992","unstructured":"Ritter JK, Chen F, Sheen YY, et al. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 1992;267:3257\u201361.","journal-title":"J Biol Chem"},{"key":"BFpr201675_CR8","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1053\/jhep.2001.24172","volume":"33","author":"J Sugatani","year":"2001","unstructured":"Sugatani J, Kojima H, Ueda A, et al. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 2001;33:1232\u20138.","journal-title":"Hepatology"},{"key":"BFpr201675_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00439-004-1183-x","volume":"115","author":"Y Maruo","year":"2004","unstructured":"Maruo Y, D\u2019Addario C, Mori A, et al. Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome. Hum Genet 2004;115:525\u20136.","journal-title":"Hum Genet"},{"key":"BFpr201675_CR10","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","volume":"333","author":"PJ Bosma","year":"1995","unstructured":"Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert\u2019s syndrome. N Engl J Med 1995;333:1171\u20135.","journal-title":"N Engl J Med"},{"key":"BFpr201675_CR11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0140-6736(96)91273-8","volume":"347","author":"G Monaghan","year":"1996","unstructured":"Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert\u2019s syndrome. Lancet 1996;347:578\u201381.","journal-title":"Lancet"},{"key":"BFpr201675_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(96)91266-0","volume":"347","author":"H Sato","year":"1996","unstructured":"Sato H, Adachi Y, Koiwai O. The genetic basis of Gilbert\u2019s syndrome. Lancet 1996;347:557\u20138.","journal-title":"Lancet"},{"key":"BFpr201675_CR13","doi-asserted-by":"publisher","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","volume":"95","author":"E Beutler","year":"1998","unstructured":"Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998;95:8170\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6 Pt 1","key":"BFpr201675_CR14","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1542\/peds.103.6.1224","volume":"103","author":"Y Maruo","year":"1999","unstructured":"Maruo Y, Nishizawa K, Sato H, Doida Y, Shimada M. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 1999;103(6 Pt 1):1224\u20137.","journal-title":"Pediatrics"},{"key":"BFpr201675_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0925-4439(98)00013-1","volume":"1406","author":"K Yamamoto","year":"1998","unstructured":"Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert\u2019s syndrome and Crigler-Najjar syndrome type II. Biochim Biophys Acta 1998;1406:267\u201373.","journal-title":"Biochim Biophys Acta"},{"key":"BFpr201675_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1203\/PDR.0b013e31822f242e","volume":"70","author":"Y Ota","year":"2011","unstructured":"Ota Y, Maruo Y, Matsui K, Mimura Y, Sato H, Takeuchi Y. Inhibitory effect of 5\u03b2-pregnane-3\u03b1,20\u03b2-diol on transcriptional activity and enzyme activity of human bilirubin UDP-glucuronosyltransferase. Pediatr Res 2011;70:453\u20137.","journal-title":"Pediatr Res"},{"key":"BFpr201675_CR17","doi-asserted-by":"publisher","first-page":"E59","DOI":"10.1542\/peds.106.5.e59","volume":"106","author":"Y Maruo","year":"2000","unstructured":"Maruo Y, Nishizawa K, Sato H, Sawa H, Shimada M. Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene. Pediatrics 2000;106:E59.","journal-title":"Pediatrics"},{"key":"BFpr201675_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jpeds.2014.01.060","volume":"165","author":"Y Maruo","year":"2014","unstructured":"Maruo Y, Morioka Y, Fujito H, et al. Bilirubin uridine diphosphate-glucuronosyltransferase variation is a genetic basis of breast milk jaundice. J Pediatr 2014;165:36\u201341.e1.","journal-title":"J Pediatr"},{"key":"BFpr201675_CR19","first-page":"125","volume":"13","author":"PL Jansen","year":"1995","unstructured":"Jansen PL, Bosma PJ, Chowdhury JR. Molecular biology of bilirubin metabolism. Prog Liver Dis 1995;13:125\u201350.","journal-title":"Prog Liver Dis"},{"key":"BFpr201675_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00043426-200101000-00010","volume":"23","author":"Y Maruo","year":"2001","unstructured":"Maruo Y, Sato H, Bamba N, et al. Chemotherapy-induced unconjugated hyperbilirubinemia caused by a mutation of the bilirubin uridine-5\u2019-diphosphate-glucuronosyltransferase gene. J Pediatr Hematol Oncol 2001;23:45\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFpr201675_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/MPG.0b013e3181fcafb8","volume":"52","author":"Y Maruo","year":"2011","unstructured":"Maruo Y, Ozgenc F, Mimura Y, et al. Compound heterozygote of a novel missense mutation (p.K402T) and a double missense mutation (p.[G71R;Y486D]) in type II Crigler-Najjar syndrome. J Pediatr Gastroenterol Nutr 2011;52:362\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"BFpr201675_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-230X-10-57","volume":"10","author":"K Matsui","year":"2010","unstructured":"Matsui K, Maruo Y, Sato H, Takeuchi Y. Combined effect of regulatory polymorphisms on transcription of UGT1A1 as a cause of Gilbert syndrome. BMC Gastroenterol 2010;10:57.","journal-title":"BMC Gastroenterol"},{"key":"BFpr201675_CR23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1046\/j.1440-1746.2001.02495.x","volume":"16","author":"T Ishihara","year":"2001","unstructured":"Ishihara T, Kaito M, Takeuchi K, et al. Role of UGT1A1 mutation in fasting hyperbilirubinemia. J Gastroenterol Hepatol 2001;16:678\u201382.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFpr201675_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.162.3853.569","volume":"162","author":"EK Wagner","year":"1968","unstructured":"Wagner EK, Roizman B. Effect of the Vinca alkaloids on RNA synthesis in human cells in vitro. Science 1968;162:569\u201370.","journal-title":"Science"},{"key":"BFpr201675_CR25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00174156","volume":"3","author":"DS Alberts","year":"1985","unstructured":"Alberts DS, Peng YM, Bowden GT, Dalton WS, Mackel C. Pharmacology of mitoxantrone: mode of action and pharmacokinetics. Invest New Drugs 1985;3:101\u20137.","journal-title":"Invest New Drugs"},{"key":"BFpr201675_CR26","first-page":"3655","volume":"43","author":"RT Kawahata","year":"1983","unstructured":"Kawahata RT, Chuang LF, Holmberg CA, Osburn BI, Chuang RY. Inhibition of human lymphoma DNA-dependent RNA polymerase activity by 6-mercaptopurine ribonucleoside triphosphate. Cancer Res 1983;43:3655\u20139.","journal-title":"Cancer Res"},{"key":"BFpr201675_CR27","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/pbc.25457","volume":"62","author":"R Berrueco","year":"2015","unstructured":"Berrueco R, Alonso-Saladrigues A, Martorell-Sampol L, et al. Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening. Pediatr Blood Cancer 2015;62:1195\u2013201.","journal-title":"Pediatr Blood Cancer"},{"key":"BFpr201675_CR28","unstructured":"Basch E, Reeve BB, Mitchell SA, et al. Development of the National Cancer Institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst 2014;106:."},{"key":"BFpr201675_CR29","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03.pdf . Accessed 28 May 2009."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr201675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201675","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T14:42:33Z","timestamp":1692283353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr201675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["BFpr201675"],"URL":"https:\/\/doi.org\/10.1038\/pr.2016.75","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,8]]},"assertion":[{"value":"14 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}